Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118312542 | 11831254 | 2 | F | 20151106 | 20151222 | 20151214 | 20160101 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-086982 | BRISTOL MYERS SQUIBB | 74.00 | YR | F | Y | 0.00000 | 20160101 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118312542 | 11831254 | 1 | PS | LYSODREN | MITOTANE | 1 | Oral | 500 MG, QD | 8000 | MG | 16885 | 500 | MG | QD | |||||
| 118312542 | 11831254 | 2 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | Unknown | UNK | 0 | ||||||||||
| 118312542 | 11831254 | 3 | C | FLUDROCORTISONE | FLUDROCORTISONE | 1 | Unknown | UNK | 0 | ||||||||||
| 118312542 | 11831254 | 4 | C | HYPERIUM | RILMENIDINE PHOSPHATE | 1 | Unknown | 0 | |||||||||||
| 118312542 | 11831254 | 5 | C | ZANIDIP | LERCANIDIPINE HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 118312542 | 11831254 | 6 | C | TAHOR | ATORVASTATIN CALCIUM | 1 | Unknown | 0 | |||||||||||
| 118312542 | 11831254 | 7 | C | INEXIUM /01479302/ | ESOMEPRAZOLE MAGNESIUM | 1 | Unknown | 0 | |||||||||||
| 118312542 | 11831254 | 8 | C | LEVETIRACETAM. | LEVETIRACETAM | 1 | Unknown | 0 | |||||||||||
| 118312542 | 11831254 | 9 | C | LYSANXIA | PRAZEPAM | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118312542 | 11831254 | 1 | Adrenocortical carcinoma |
| 118312542 | 11831254 | 2 | Product used for unknown indication |
| 118312542 | 11831254 | 3 | Product used for unknown indication |
| 118312542 | 11831254 | 4 | Product used for unknown indication |
| 118312542 | 11831254 | 5 | Product used for unknown indication |
| 118312542 | 11831254 | 6 | Product used for unknown indication |
| 118312542 | 11831254 | 7 | Product used for unknown indication |
| 118312542 | 11831254 | 8 | Product used for unknown indication |
| 118312542 | 11831254 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118312542 | 11831254 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118312542 | 11831254 | Oedema mouth | |
| 118312542 | 11831254 | Oedema peripheral | |
| 118312542 | 11831254 | Pruritus | |
| 118312542 | 11831254 | Rash maculo-papular |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118312542 | 11831254 | 1 | 20151022 | 20151109 | 0 | |
| 118312542 | 11831254 | 2 | 20151022 | 0 | ||
| 118312542 | 11831254 | 3 | 20151022 | 0 |